Referral Sources
Medical genetics, cardiology, hepatology and neurology clinics that already manage the underlying condition, along with rare-disease advocacy groups. Many patients find studies on their own after years in a specialty clinic.
Patients Exploring Gene Editing Want to Match With You
People living with genetic conditions are reading about in vivo editing and looking for practices that can talk to them about it. Be the one they choose.
Patients swipe on the practices they like. When you swipe back — it’s a match!
Free to join. No card required.
Who’s Looking
The Patients Searching for In Vivo CRISPR Gene Editing
These patients have usually lived with a diagnosis for years and know their condition well. Many already have genetic test results in hand. What they lack is a clear way to find the practices and research teams working in this field.
On Health e Match they list what they are living with and that they are exploring gene editing. When your profile shows that you treat it, they can choose your practice first.
Typical Patient
An adult, or the parent of a child, with a confirmed genetic diagnosis, test results in hand and a long treatment history, who wants to know whether they meet a study’s criteria and what follow-up would involve.
Your Profile
Show Patients What You Offer
Your profile is where a patient decides. Describe in vivo CRISPR gene editing the way you offer it, your clinicians and their credentials, and the regulatory status of each therapy in your own words.
- Studies Enrolling Now. The conditions and phase of each study you are recruiting for.
- Genetic Counseling. Whether counseling and confirmatory testing are available in-house.
- Eligibility Basics. The headline criteria a patient can check before choosing you, as your approved materials state them.
- Follow-Up Commitment. How long monitoring lasts and how often visits happen, in plain terms.
- Regulatory Status. Investigational, stated exactly as your study documents it.
Why Practices Join
Warm Patients, Not Cold Leads
-
Patients Make the First Move
They read your profile and swipe on you first. You’re notified the moment one does.
-
You Choose Your Patients
Swipe back on the ones who fit your practice. Pass on the ones who don’t.
-
Your Credentials Do the Talking
Your NPI is checked against the national registry, and your license and coverage are reviewed before you go live.
-
Nothing Rings the Front Desk
Messaging takes place on healthematch.com, after you’ve swiped back.
Questions
What Practices Ask
We are a trial site. Can we be on Health e Match?
Yes. Your profile describes what your practice offers, including investigational therapies, with the regulatory status shown exactly as you document it. Your study’s own rules on recruitment and eligibility still apply, and the decision about any patient is always yours.
Will patients understand that this is investigational?
Investigational status is shown in your own words before a patient ever swipes. We do not soften it and we do not embellish it.
Do we need IRB approval for what we put on our profile?
If your profile describes a study you are recruiting for, treat it like any other recruitment material and follow your IRB’s requirements. Health e Match shows what you write; it does not edit it or add claims.
Can we list conditions we treat outside the study?
Yes. Describe your clinical care as well as your research. A patient who does not qualify for a study may still need your clinic.
Start Matching Today
Build your practice profile once, list in vivo CRISPR gene editing among what you offer, and let patients who are looking for it choose you.
Free to join. No card required.
healthematch.com makes introductions between patients and practices in the United States. It does not provide medical advice, diagnosis, or treatment, does not recruit for or enroll anyone in clinical research, and does not recommend any particular procedure or provider. A practice listing an investigational therapy remains responsible for its own study’s recruitment and eligibility requirements. Looking for care? See the in vivo CRISPR gene editing page for patients.